» Articles » PMID: 31766248

Mumefural Ameliorates Cognitive Impairment in Chronic Cerebral Hypoperfusion Via Regulating the Septohippocampal Cholinergic System and Neuroinflammation

Overview
Journal Nutrients
Date 2019 Nov 27
PMID 31766248
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic cerebral hypoperfusion (CCH) causes cognitive impairment and neurogenic inflammation by reducing blood flow. We previously showed that () improves cognitive impairment and inhibits neuroinflammation in a CCH rat model. One of the components of , Mumefural (MF), is known to improve blood flow and inhibit platelet aggregation. Whether MF affects cerebral and cognitive function remains unclear. We investigated the effects of MF on cognitive impairment and neurological function-related protein expression in the rat CCH model, established by bilateral common carotid arterial occlusion (BCCAo). Three weeks after BCCAo, MF (20, 40, or 80 mg/kg) was orally administrated once a day for 42 days. Using Morris water maze assessment, MF treatment significantly improved cognitive impairment. MF treatment also inhibited cholinergic system dysfunction, attenuated choline acetyltransferase-positive cholinergic neuron loss, and regulated cholinergic system-related protein expressions in the basal forebrain and hippocampus. MF also inhibited myelin basic protein degradation and increased the hippocampal expression of synaptic markers and cognition-related proteins. Moreover, MF reduced neuroinflammation, inhibited gliosis, and attenuated the activation of P2X7 receptor, TLR4/MyD88, NLRP3, and NF-κB. This study indicates that MF ameliorates cognitive impairment in BCCAo rats by enhancing neurological function and inhibiting neuroinflammation.

Citing Articles

The low and high doses administration of lutein improves memory and synaptic plasticity impairment through different mechanisms in a rat model of vascular dementia.

Asadi Nejad H, Yousefi Nejad A, Akbari S, Naseh M, Shid Moosavi S, Haghani M PLoS One. 2024; 19(5):e0302850.

PMID: 38748711 PMC: 11095768. DOI: 10.1371/journal.pone.0302850.


ChemR23 activation attenuates cognitive impairment in chronic cerebral hypoperfusion by inhibiting NLRP3 inflammasome-induced neuronal pyroptosis.

Zhang Y, Zhang J, Zhao Y, Zhang Y, Liu L, Xu X Cell Death Dis. 2023; 14(11):721.

PMID: 37932279 PMC: 10628255. DOI: 10.1038/s41419-023-06237-6.


Mumefural Improves Recognition Memory and Alters ERK-CREB-BDNF Signaling in a Mouse Model of Chronic Cerebral Hypoperfusion.

Kim M, Kim B, Kim J, Lee J, Jeon W Nutrients. 2023; 15(14).

PMID: 37513692 PMC: 10383324. DOI: 10.3390/nu15143271.


Network Pharmacology and Molecular Docking-Based Investigation: Against Colorectal Cancer via Silencing Expression.

Zhou M, Li J, Luo D, Zhang H, Yu Z, Chen Y Front Pharmacol. 2021; 12:761980.

PMID: 34867383 PMC: 8640358. DOI: 10.3389/fphar.2021.761980.


Upregulation of TRPC5 in hippocampal excitatory synapses improves memory impairment associated with neuroinflammation in microglia knockout IL-10 mice.

Huo S, Ren J, Ma Y, Ozathaley A, Yuan W, Ni H J Neuroinflammation. 2021; 18(1):275.

PMID: 34836549 PMC: 8620645. DOI: 10.1186/s12974-021-02321-w.


References
1.
Hase Y, Craggs L, Hase M, Stevenson W, Slade J, Lopez D . Effects of environmental enrichment on white matter glial responses in a mouse model of chronic cerebral hypoperfusion. J Neuroinflammation. 2017; 14(1):81. PMC: 5387261. DOI: 10.1186/s12974-017-0850-5. View

2.
Kim M, Bang J, Lee J, Kim H, Sung S, Han J . Salvia miltiorrhiza extract protects white matter and the hippocampus from damage induced by chronic cerebral hypoperfusion in rats. BMC Complement Altern Med. 2015; 15:415. PMC: 4657337. DOI: 10.1186/s12906-015-0943-6. View

3.
Bours M, Dagnelie P, Giuliani A, Wesselius A, Di Virgilio F . P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation. Front Biosci (Schol Ed). 2011; 3(4):1443-56. DOI: 10.2741/235. View

4.
Meyer J, Rauch G, Rauch R, Haque A . Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiol Aging. 2000; 21(2):161-9. DOI: 10.1016/s0197-4580(00)00136-6. View

5.
Wang J, Zhang H, Tang X . Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion. J Neurosci Res. 2009; 88(4):807-15. DOI: 10.1002/jnr.22237. View